On October 22, 2026, the Department of Justice (“DOJ”) Civil Division and the Department of Health and Human Services (“HHS”) announced a six-month Healthcare False Claims Act Self-Disclosure Pilot Program […]
On October 15, 2026, the Department of Justice’s National Fraud Enforcement Division (“NFED”) and the Department of Health and Human Services Office of Inspector General (“HHS-OIG”) announced a joint policy […]
On September 23, 2026, Jeanine Pirro, the U.S. Attorney for the District of Columbia, announced the creation of a new Fraud and Asset Recovery Division. The new Division will be […]
In a move with substantial implications for federal enforcement generally and the False Claims Act (“FCA”) in particular, the U.S. Department of Justice (“the Department”) on September 18, 2026 announced […]
On August 13, 2026, Assistant Attorney General Colin M. McDonald of the Department of Justice’s (DOJ) National Fraud Enforcement Division (NFED) issued a memorandum outlining the Division’s mission, organizational structure, and enforcement priorities (the Memo). The White House established NFED in April 2026. As discussed in a prior Sidley update, NFED is tasked with leading a whole-of-government effort to combat fraud “no matter its size or complexity.”
The Memo provides the most detailed public account to date of NFED’s mission, structure and enforcement approach and further underscores the Administration’s focus on anti-fraud enforcement as a signature initiative.
This blog post highlights four key takeaways from the Memo and offers observations for companies navigating this evolving enforcement landscape. Click here to read the full post.
On August 5, 2026, DOJ announced a $5.15 million settlement with a Taiwanese light-emitting diode (“LED”) manufacturer and its Texas-based subsidiary to resolve allegations under the False Claims Act (“FCA”), […]
On August 4, 2026, DOJ’s National Fraud Enforcement Division (“Fraud Division”) announced a significant expansion of its Northeast Health Care Fraud Strike Force into Philadelphia. The expansion will reunite the […]
On July 29, 2026, the Department of Justice (“DOJ”) announced that, consistent with Part I of DOJ’s Department-wide Corporate Enforcement and Voluntary Self-Disclosure Policy (“CEP”), it declined to prosecute Campus Eye Management Holdings LLC and its wholly owned subsidiary, Campus Eye Management LLC (collectively, “Campus Eye”), a management services organization that provided billing and other services to an optometry practice and ambulatory surgery center. DOJ had been investigating Campus Eye for alleged healthcare fraud, including illegal kickbacks. This is the first declination involving a healthcare company under the new, Department-wide CEP. And it is only the second healthcare fraud declination under any voluntary self-disclosure policy in DOJ history—the first being the HealthSun Health Plans, Inc. matter handled by the same team (i.e., the Health Care Fraud Unit) when they were part of the Criminal Division’s Fraud Section, prior to creation of the National Fraud Enforcement Division (“NFED”) earlier this year. Click here to read the full blog post.